Literature DB >> 34155495

Advances of smart nano-drug delivery systems in osteosarcoma treatment.

Ying Liu1, Qing Li1, Qian Bai1, Wei Jiang1.   

Abstract

Nanotechnology has recently become popular due to its potential for biomedical applications, especially for cancer treatment. Nanotechnology, featuring responsiveness to stimuli and stable drug release, has been widely used for the delivery of chemotherapeutic drugs, which are commonly used in the treatment of osteosarcoma. Smart stimuli-responsive nanotechnology is expected to improve the treatment of osteosarcoma. Herein, we focus on the latest research on nanomaterials in treating osteosarcoma that respond to internal and external stimuli. We also discuss nanocarriers with targeting ligands and the use of smart nanotechnology to partially reverse the multidrug resistance of osteosarcoma.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34155495     DOI: 10.1039/d1tb00566a

Source DB:  PubMed          Journal:  J Mater Chem B        ISSN: 2050-750X            Impact factor:   6.331


  2 in total

1.  Hybrid biomimetic assembly enzymes based on ZIF-8 as "intracellular scavenger" mitigating neuronal damage caused by oxidative stress.

Authors:  Qing Li; Ruixia Feng; Zhaohui Chang; Xiaojun Liu; Hao Tang; Qian Bai
Journal:  Front Bioeng Biotechnol       Date:  2022-08-31

2.  Doxorubicin-Loaded Lipid Nanoparticles Coated with Calcium Phosphate as a Potential Tool in Human and Canine Osteosarcoma Therapy.

Authors:  Daniela Chirio; Simona Sapino; Giulia Chindamo; Elena Peira; Cristina Vercelli; Chiara Riganti; Maela Manzoli; Graziana Gambino; Giovanni Re; Marina Gallarate
Journal:  Pharmaceutics       Date:  2022-06-27       Impact factor: 6.525

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.